Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

Affiliations

• ¹ Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
• ² UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
• ³ Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA.
• ⁴ Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.
• ⁵ Centers for Disease Control and Prevention, Atlanta, GA, USA.
• ⁶ University of Nebraska Medical Center, Omaha, NE, USA.
• ⁷ Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MA, USA.
• ⁸ Medical University of South Carolina, Charleston, SC, USA.
• ⁹ Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
• ¹⁰ Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda.
• ¹¹ University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System, San Antonio, TX, USA.
• ¹² St. George's, University of London, London, UK.
• ¹³ Division of Infectious Diseases, Vanderbilt University, Nashville, TN, USA.
• ¹⁴ TASK, Cape Town, Western Cape, Cape Town, South Africa.
• ¹⁵ Vietnam National Tuberculosis Program-University of California, San Francisco Research Collaboration Unit, Hanoi, Vietnam.
• ¹⁶ National Lung Hospital, Hanoi, Vietnam.
• ¹⁷ Lung Institute and Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
• ¹⁸ Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. rada.savic@ucsf.edu.
• ¹⁹ UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA. rada.savic@ucsf.edu.